Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]

HER2-positive breast cancer: Predicting pCR from clinicopathologic variables...

Dr Nadine M Tung - Beth Israel Deaconess Medical Center, Boston, USA

HER2-positive breast cancer: Predicting pCR from clinicopathologic variables and genomic testing ( Dr Nadine M Tung - Beth Israel Deaconess Medical Center, Boston, USA )

Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic...

Dr Vincent Picozzi - Virginia Mason Medical Center, Seattle, USA

Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic cancer ( Dr Vincent Picozzi - Virginia Mason Medical Center, Seattle, USA )

Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

BCG combined with mitomycin offers improved adjuvant treatment regimen for high...

Prof Dickon Hayne - University of Western Australia, Perth, Australia

BCG combined with mitomycin offers improved adjuvant treatment regimen for high-risk NMIBC ( Prof Dickon Hayne - University of Western Australia, Perth, Australia )

ASCO 2025: Latest in EGFR positive NSCLC

Prof Pascale Tomasini, Prof Enriqueta Felip, Prof Nicolas Girard

ASCO 2025: Latest in EGFR positive NSCLC ( Prof Pascale Tomasini, Prof Enriqueta Felip, Prof Nicolas Girard )

Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2...

Prof Sung-Bae Kim - Asan Medical Center, Seoul, South Korea

Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2-negative mBC ( Prof Sung-Bae Kim - Asan Medical Center, Seoul, South Korea )

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma

Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma ( Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands )

Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer

Dr Jean Abraham - University of Cambridge, Cambridge, UK

Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer ( Dr Jean Abraham - University of Cambridge, Cambridge, UK )

Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective

Dr Ricky Frazer and Dr Sree Subramanian

Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective ( Dr Ricky Frazer and Dr Sree Subramanian )

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid...

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )

ELCC 2025: Latest in EGFR positive NSCLC

Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna...

ELCC 2025: Latest in EGFR positive NSCLC ( Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom )

More from ecancer